vs
Side-by-side financial comparison of Autolus Therapeutics plc (AUTL) and HARTE HANKS INC (HHS). Click either name above to swap in a different company.
HARTE HANKS INC is the larger business by last-quarter revenue ($39.9M vs $21.2M, roughly 1.9× Autolus Therapeutics plc). HARTE HANKS INC runs the higher net margin — 5.5% vs -373.3%, a 378.8% gap on every dollar of revenue. HARTE HANKS INC produced more free cash flow last quarter ($-686.0K vs $-72.3M).
Autolus Therapeutics plc is a clinical-stage biopharmaceutical company specializing in the development of next-generation engineered chimeric antigen receptor T-cell (CAR-T) therapies for the treatment of hematological malignancies and solid tumors. It operates in the global oncology biotech market, advancing a pipeline of targeted immunotherapy candidates across multiple clinical development stages.
Harte Hanks is a global marketing services company headquartered in Boston, Massachusetts. Harte Hanks services include analytics, strategy, marketing technology, creative services, digital marketing, customer care, direct mail, logistics, and fulfillment.
AUTL vs HHS — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $21.2M | $39.9M |
| Net Profit | $-79.1M | $2.2M |
| Gross Margin | — | — |
| Operating Margin | -337.9% | -0.3% |
| Net Margin | -373.3% | 5.5% |
| Revenue YoY | — | -15.4% |
| Net Profit YoY | 3.6% | — |
| EPS (diluted) | $-0.30 | $0.30 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $39.9M | ||
| Q3 25 | $21.2M | $39.5M | ||
| Q2 25 | $20.9M | $38.6M | ||
| Q1 25 | $9.0M | $41.6M | ||
| Q4 24 | — | $47.1M | ||
| Q3 24 | $0 | $47.6M | ||
| Q2 24 | $0 | $45.0M | ||
| Q1 24 | $10.1M | $45.4M |
| Q4 25 | — | $2.2M | ||
| Q3 25 | $-79.1M | $-2.3M | ||
| Q2 25 | $-47.9M | $-335.0K | ||
| Q1 25 | $-70.2M | $-392.0K | ||
| Q4 24 | — | — | ||
| Q3 24 | $-82.1M | $142.0K | ||
| Q2 24 | $-58.3M | $-27.8M | ||
| Q1 24 | $-52.7M | $-171.0K |
| Q4 25 | — | -0.3% | ||
| Q3 25 | -337.9% | 1.3% | ||
| Q2 25 | -292.6% | 0.1% | ||
| Q1 25 | -726.3% | -0.1% | ||
| Q4 24 | — | -3.3% | ||
| Q3 24 | — | 4.0% | ||
| Q2 24 | — | 3.0% | ||
| Q1 24 | -384.1% | 0.8% |
| Q4 25 | — | 5.5% | ||
| Q3 25 | -373.3% | -5.8% | ||
| Q2 25 | -229.0% | -0.9% | ||
| Q1 25 | -781.1% | -0.9% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | -61.8% | ||
| Q1 24 | -522.1% | -0.4% |
| Q4 25 | — | $0.30 | ||
| Q3 25 | $-0.30 | $-0.31 | ||
| Q2 25 | $-0.18 | $-0.05 | ||
| Q1 25 | $-0.26 | $-0.05 | ||
| Q4 24 | — | $-0.31 | ||
| Q3 24 | $-0.31 | $0.02 | ||
| Q2 24 | $-0.22 | $-3.84 | ||
| Q1 24 | $-0.24 | $-0.02 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $86.1M | $5.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $265.5M | $20.5M |
| Total Assets | $661.9M | $91.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $5.6M | ||
| Q3 25 | $86.1M | $6.5M | ||
| Q2 25 | $123.8M | $4.8M | ||
| Q1 25 | $95.8M | $9.0M | ||
| Q4 24 | — | $9.8M | ||
| Q3 24 | $657.1M | $5.9M | ||
| Q2 24 | $705.9M | $11.0M | ||
| Q1 24 | $758.5M | $11.5M |
| Q4 25 | — | $20.5M | ||
| Q3 25 | $265.5M | $19.9M | ||
| Q2 25 | $346.5M | $22.2M | ||
| Q1 25 | $371.1M | $21.4M | ||
| Q4 24 | — | $21.7M | ||
| Q3 24 | $477.0M | $21.0M | ||
| Q2 24 | $527.8M | $20.6M | ||
| Q1 24 | $582.0M | $20.0M |
| Q4 25 | — | $91.8M | ||
| Q3 25 | $661.9M | $92.7M | ||
| Q2 25 | $721.0M | $95.0M | ||
| Q1 25 | $746.3M | $100.6M | ||
| Q4 24 | — | $101.8M | ||
| Q3 24 | $827.5M | $108.1M | ||
| Q2 24 | $853.6M | $109.7M | ||
| Q1 24 | $901.4M | $113.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-67.9M | $737.0K |
| Free Cash FlowOCF − Capex | $-72.3M | $-686.0K |
| FCF MarginFCF / Revenue | -341.2% | -1.7% |
| Capex IntensityCapex / Revenue | 20.8% | 3.6% |
| Cash ConversionOCF / Net Profit | — | 0.33× |
| TTM Free Cash FlowTrailing 4 quarters | $-322.5M | $-4.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $737.0K | ||
| Q3 25 | $-67.9M | $3.2M | ||
| Q2 25 | $-72.8M | $-4.8M | ||
| Q1 25 | $-75.6M | $-818.0K | ||
| Q4 24 | — | $4.0M | ||
| Q3 24 | $-76.7M | $-2.9M | ||
| Q2 24 | $-51.1M | $1.6M | ||
| Q1 24 | $-40.5M | $-5.7M |
| Q4 25 | — | $-686.0K | ||
| Q3 25 | $-72.3M | $2.2M | ||
| Q2 25 | $-80.1M | $-5.1M | ||
| Q1 25 | $-83.8M | $-923.0K | ||
| Q4 24 | — | $3.4M | ||
| Q3 24 | $-86.3M | $-4.9M | ||
| Q2 24 | $-51.9M | $926.0K | ||
| Q1 24 | $-41.0M | $-6.2M |
| Q4 25 | — | -1.7% | ||
| Q3 25 | -341.2% | 5.5% | ||
| Q2 25 | -382.6% | -13.1% | ||
| Q1 25 | -933.1% | -2.2% | ||
| Q4 24 | — | 7.3% | ||
| Q3 24 | — | -10.2% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | -406.8% | -13.7% |
| Q4 25 | — | 3.6% | ||
| Q3 25 | 20.8% | 2.5% | ||
| Q2 25 | 34.8% | 0.6% | ||
| Q1 25 | 91.8% | 0.3% | ||
| Q4 24 | — | 1.3% | ||
| Q3 24 | — | 4.0% | ||
| Q2 24 | — | 1.5% | ||
| Q1 24 | 5.3% | 1.2% |
| Q4 25 | — | 0.33× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -20.76× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AUTL
Segment breakdown not available.
HHS
| Fulfillment And Logistics Services | $17.3M | 43% |
| Customer Care | $13.7M | 34% |
| Other | $8.9M | 22% |
